Since BRCA1 defects are closely associated with susceptibility to breast cancer, ovarian cancer, and prostate cancer, CDK12 mutation has been similarly related to the susceptibility of these cancers, with a defect in the double-strand break repair mechanism mediated by DDR and HR defined as “BRCAness”41,42. This evidence concerns the gene CDK12 and prostate cancer.